Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50022712
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Mouse)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Mouse)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Mouse)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 5.80nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Mouse)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 7.70nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA in presence of 8 uM ATPMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 370nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.13E+3nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.47E+3nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.58E+3nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.90E+3nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3.12E+3nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.32E+4nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.57E+4nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.36E+4nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA in presence of 8 uM ATPMore data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 3.30E+4nMAssay Description:Agonist activity at human recombinant 5HT2B receptor by cell-based systemMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4.60E+4nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
Ligand Info
TargetNACHT, LRR and PYD domains-containing protein 3(Human)
Novartis Biomedical Research
Curated by ChEMBL
Novartis Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISAMore data for this Ligand-Target Pair
















